UNIVERSITY OF ROCHESTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1850-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.rochester.edu
Serologic Response to the SARS-CoV-2 (COVID-19) MRNA-1273 Vaccine in Select Subsets of Oncology Patients
Completed
- Conditions
- Covid19Cancer
- Interventions
- Other: Blood Sample
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 8
- Registration Number
- NCT04854980
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)
Not Applicable
Terminated
- Conditions
- Cancer
- Interventions
- Behavioral: Behavioral
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 21
- Registration Number
- NCT04824859
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
Not Applicable
Recruiting
- Conditions
- Atrial FibrillationHeart Failure
- Interventions
- Device: ASSERT Insertable Cardiac MonitorOther: Conventional Management and monitoring
- First Posted Date
- 2021-03-26
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 477
- Registration Number
- NCT04818645
- Locations
- 🇺🇸
University of Rochester Medical Center, Rochester, New York, United States
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
Not Applicable
Recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- Radiation: Acupuncture-Like Transcutaneous Electrical Stimulation (ALTENS)
- First Posted Date
- 2021-03-18
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 75
- Registration Number
- NCT04805528
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
The Effects of a 12 Week Home-based Exercise Intervention on Physical Performance in Patients With Cancers of the Gastrointestinal Tract With Pre- Cachexia or Cachexia
Not Applicable
Completed
- Conditions
- CachexiaWeight LossGastrointestinal Cancer
- Interventions
- Other: EXCAP©®
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2021-03-17
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 25
- Registration Number
- NCT04802486
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Visual Rehabilitation After Occipital Stroke
Not Applicable
Active, not recruiting
- Conditions
- Vision Loss PartialQuadrantanopiaVisual Field Defect, PeripheralPeripheral Visual Field DefectHemianopsiaHemianopiaVisual Fields HemianopsiaHomonymous HemianopsiaOccipital Lobe InfarctStroke, Ischemic
- Interventions
- Device: Subacute Training in the blind fieldDevice: Subacute Training in the intact fieldDevice: Chronic Training in the blind field
- First Posted Date
- 2021-03-15
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 60
- Registration Number
- NCT04798924
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 25
- Registration Number
- NCT04792190
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸Henry Ford Hospital, Detroit, Michigan, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Not Applicable
Completed
- Conditions
- Myelodysplastic SyndromesAcute Myeloid Leukemia
- Interventions
- Behavioral: Telehealth
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 36
- Registration Number
- NCT04745676
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
Phase 2
Recruiting
- Conditions
- Prostate CancerMultiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma (SMM)
- Interventions
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 40
- Registration Number
- NCT04731844
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye
Phase 4
Withdrawn
- Conditions
- Retinopathy, Diabetic
- Interventions
- Drug: Sham injection
- First Posted Date
- 2021-01-08
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- University of Rochester
- Registration Number
- NCT04702048
- Locations
- 🇺🇸
Flaum Eye Institute, University of Rochester Medical Center, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath